Insider Transactions in Q4 2021 at Oak Street Health, Inc. (OSH)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Grant, award, or other acquisition
|
Direct |
417
-0.01%
|
$11,676
$28.17 P/Share
|
|
Dec 28
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.59%
|
$935,000
$34.49 P/Share
|
|
Dec 21
2021
|
Michael T Pykosz Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,761
+0.06%
|
$99,981
$21.0 P/Share
|
|
Dec 17
2021
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,716
+0.12%
|
$99,036
$21.0 P/Share
|
|
Dec 16
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,533
-0.28%
|
$78,523
$31.92 P/Share
|
|
Dec 14
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.59%
|
$880,000
$32.24 P/Share
|
|
Dec 08
2021
|
Griffin Myers Chief Medical Officer |
SELL
Bona fide gift
|
Indirect |
8,500
-0.18%
|
-
|
|
Dec 08
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
20,000
-4.28%
|
-
|
|
Dec 07
2021
|
Robert Guenthner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.07%
|
$210,000
$21.0 P/Share
|
|
Dec 02
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
419
-0.09%
|
$12,989
$31.44 P/Share
|
|
Nov 23
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.29%
|
$852,500
$31.87 P/Share
|
|
Nov 18
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,476
-0.16%
|
$54,612
$37.13 P/Share
|
|
Nov 16
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.34%
|
$2,000,000
$40.01 P/Share
|
|
Nov 16
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
86,017
-1.62%
|
$3,440,680
$40.3 P/Share
|
|
Nov 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
23,383
-0.44%
|
$935,320
$40.0 P/Share
|
|
Nov 09
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
28,100
-0.2%
|
$1,124,000
$40.56 P/Share
|
|
Nov 04
2021
|
Julie D Klapstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+21.38%
|
-
|
|
Nov 04
2021
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+34.73%
|
-
|
|
Nov 04
2021
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+2.18%
|
-
|
|
Nov 04
2021
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+5.3%
|
-
|
|
Nov 04
2021
|
Cheryl Dorsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+24.14%
|
-
|
|
Nov 04
2021
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,447
+0.94%
|
-
|
|
Nov 04
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,902
-0.43%
|
$271,492
$46.1 P/Share
|
|
Nov 02
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.17%
|
$2,300,000
$46.55 P/Share
|
|
Oct 28
2021
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.58%
|
$690,000
$46.53 P/Share
|
|
Oct 26
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
72,500
-1.46%
|
$3,262,500
$45.65 P/Share
|
|
Oct 21
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,328
-0.55%
|
$464,760
$45.52 P/Share
|
|
Oct 19
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$2,100,000
$42.03 P/Share
|
|
Oct 15
2021
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
109,400
-1.0%
|
$4,485,400
$41.99 P/Share
|
|
Oct 12
2021
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
27,500
-0.37%
|
$1,017,500
$37.2 P/Share
|
|
Oct 07
2021
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,476
-0.16%
|
$60,516
$41.42 P/Share
|
|
Oct 05
2021
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-0.33%
|
$2,050,000
$42.0 P/Share
|